Navigation Links
Capsule endoscopy turning up undiagnosed cases of Crohn's disease
Date:10/16/2007

WINSTON-SALEM, N.C. A small capsule that takes snapshots of the small intestine as it moves through the digestive tract helped doctors spot cases of Crohns disease that had gone undiagnosed for up to 15 years, according to researchers at Wake Forest University Baptist Medical Center.

Reporting this week at the American College of Gastroenterologys meeting in Philadelphia, the researchers said that of 198 video capsule endoscopies that were performed to evaluate unexplained gastrointestinal bleeding, physicians found six cases of Crohns disease that hadnt been diagnosed previously, despite the patients having colonoscopies and a variety of other imaging tests.

The study is the first to evaluate the prevalence of the Crohns disease (about 3 percent) among patients having capsule endoscopy to evaluate unexplained bleeding.

With capsule endoscopy, we were able to diagnose cases that previously were difficult or impossible to diagnose, said Richard Bloomfeld, M.D., gastroenterologist and senior researcher. Some of the patients had been having transfusions for years because of anemia from unexplained bleeding.

The research was presented by Sakeitha Crowder, M.D., a resident in internal medicine.

Capsule endoscopy has become a standard tool to evaluate unexplained bleeding in the stomach and intestines. Patients swallow a small capsule containing a video camera that takes two images per second over eight hours.

It allows us to see 20 feet of small intestine between the stomach and large intestine areas that we cannot reach with other tests, said Bloomfeld. Its easy, painless and requires no sedation.

Crohns disease is a disorder that causes inflammation of the digestive tract. It is generally easy to diagnose with a colonoscopy or through symptoms that include abdominal pain and diarrhea. In some cases, however, the disease affects part of the intestine that cannot be reached with colonoscopy.


'/>"/>
Contact: Karen Richardson
krchrdsn@wfubmc.edu
336-716-4453
Wake Forest University Baptist Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Warning issued by FDA over "Liqiang 4 Capsules"
3. Medical Boon in the Form of a Biofriendly Capsule
4. Fish Oil Capsules Could Enhance Brainpower in Children
5. Ranbaxy Ties Up With US Co For Mktg Zonisamide Capsules
6. Microcapsules target cancer cells
7. Ranbaxy Launches Asthma Inhalation Capsule in India
8. Mylan Announces Final FDA Approval for Fluoxetine Capsules
9. Capsule Endoscopy is Effective in Diagnosing GI Problems Children
10. When CIAs Poisoned Capsule for Castro Stuck to the Freezer!
11. Tamiflu 30 Mg and 45 Mg Capsules Approved by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 2Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 3Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 4Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 5Health News:Schlafender Hase Releases Text Verification Tool 4.0 2Health News:Family counseling improves lives of patients and spouses coping with prostate cancer 2Health News:Factor key to severity of community-associated methicillin-resistant staph infections identified 2Health News:Factor key to severity of community-associated methicillin-resistant staph infections identified 3Health News:New Test Criteria Spots Rheumatoid Arthritis Sooner 2Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 2Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 3Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 4Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 5Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 6